Method and apparatus for controlling an exchange
    1.
    发明授权
    Method and apparatus for controlling an exchange 失效
    用于控制交换的方法和装置

    公开(公告)号:US5822422A

    公开(公告)日:1998-10-13

    申请号:US710812

    申请日:1996-09-23

    IPC分类号: G06F13/00 H04M3/00 H04Q3/545

    CPC分类号: H04Q3/5455

    摘要: A method of controlling an exchange (NE), and a communications system which comprises at least one such exchange (NE) and a management system (OS). The exchange (NE) is controlled by a number of application programs. The application programs are assigned to two different control units (CONTR1; CONTR2), namely a first and a second control unit (CONTR1; CONTR2), with different operating system platforms. One part of the application programs runs on an operating system platform of the first control unit (CONTR1), which is specifically adapted for the performance of switching functions. The other part of the application programs which is assigned to the second control unit (CONTR2), runs on a universal operating system platform. In this case the application programs of the first control unit (CONTR1) cooperate with the application programs of the second control unit (CONTR2) to provide switching functions.

    摘要翻译: 一种控制交换(NE)的方法,以及包括至少一个此类交换(NE)和管理系统(OS)的通信系统。 交易所(NE)由多个应用程序控制。 应用程序分配给两个不同的控制单元(CONTR1; CONTR2),即第一个和第二个控制单元(CONTR1; CONTR2),具有不同的操作系统平台。 应用程序的一部分在第一控制单元(CONTR1)的操作系统平台上运行,该平台专门用于切换功能的执行。 分配给第二控制单元(CONTR2)的应用程序的另一部分在通用操作系统平台上运行。 在这种情况下,第一控制单元(CONTR1)的应用程序与第二控制单元(CONTR2)的应用程序协作以提供切换功能。

    Trans-sialidases obtained from Trypanosoma congolense
    7.
    发明授权
    Trans-sialidases obtained from Trypanosoma congolense 失效
    来自锥虫的转唾液酸酶

    公开(公告)号:US07655784B2

    公开(公告)日:2010-02-02

    申请号:US10538840

    申请日:2003-12-11

    IPC分类号: C07H21/02 C07H21/04 A61K39/00

    CPC分类号: C12N9/1081

    摘要: The invention relates to novel enzymes, which transfer sialic acid from a donor molecule onto an acceptor molecule (trans-sialidases). The enzymes are isolated from the protozoan Trypanosoma congolense. The invention also relates to functional equivalents of said enzymes, to the nucleic acid sequences and amino acid sequences that code for the enzymes and their functional equivalents, to expression constructs and vectors that contain said sequences, to recombinant microorganisms that carry the inventive coding nucleic-acid sequences, to a method for the recombinant production of the inventive enzymes, to a method for isolating said enzyme from Trypanosoma congolense, to a method for the enzymatic sialization of acceptor molecules using the inventive enzymes, to effectors of the inventive trans-sialidases, to the use of the nucleic acid sequences, amino acid sequences, enzymes, effectors or sialization products for producing vaccines, medicaments, foodstuffs or food additives, in addition to the latter products obtained by the inventive method.

    摘要翻译: 本发明涉及将唾液酸从供体分子转移到受体分子(反唾液酸酶)上的新型酶。 这些酶是从原生动物锥虫中分离的。 本发明还涉及所述酶的功能等同物,编码酶及其功能等同物的核酸序列和氨基酸序列,含有所述序列的表达构建体和载体,携带本发明编码核酸的重组微生物, 酸序列,重组生产本发明酶的方法,用于将所述酶与锥虫属分离的方法,使用本发明酶将受体分子酶促唾液酸化的方法用于本发明的反唾液酸酶的实施者, 使用除了通过本发明方法获得的后一种产品之外的核酸序列,氨基酸序列,酶,效应物或用于生产疫苗,药物,食品或食品添加剂的唾液化产品。

    CARBOHYDRATES MIXTURE
    8.
    发明申请
    CARBOHYDRATES MIXTURE 有权
    碳酸氢钾混合物

    公开(公告)号:US20100016214A1

    公开(公告)日:2010-01-21

    申请号:US12565512

    申请日:2009-09-23

    摘要: A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided according to the present invention. Said carbohydrate mixture is characterized in that they contain or consist of two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed, that said carbohydrate component A is composed of at least one monosaccharide or of at least one oligosaccharide (disaccharide to hexasaccharide) or of a mixture of two or more of these saccharides, that the carbohydrate component B is composed of a polysaccharide (from heptasaccharide onwards) or of a mixture of two or more polysaccharides, that the carbohydrate component A=5 to 95 wt-% and the carbohydrate component B=5 to 95 wt-% of the sum of the carbohydrate components A+B (=100 wt-%), and that at least 80 wt-% of the carbohydrates/saccharides of the carbohydrate components A and B have a prebiotic effect. The inventive carbohydrate mixture have not only a nutritive effect but they also stimulate health-promoting microorganisms present in the natural flora of the large intestine.

    摘要翻译: 根据本发明提供了含有几种碳水化合物的饮食食品和药物的碳水化合物混合物。 所述碳水化合物混合物的特征在于它们含有两种不同的,基本上可溶的碳水化合物组分A和B,其中所述碳水化合物组分A和B在胃肠道中未消化并进入大肠而不被再吸收,所述碳水化合物组分A由至少一种 单糖或至少一种寡糖(二糖与六糖)或两种或多种这些糖的混合物,碳水化合物组分B由多糖(来自七糖以上)或两种或多种多糖的混合物组成,该 碳水化合物组分A = 5至95重量%,碳水化合物组分B = 5至95重量%的碳水化合物组分A + B(= 100重量%)和至少80重量%的碳水化合物组分 碳水化合物组分A和B的碳水化合物/糖具有益生元效应。 本发明的碳水化合物混合物不仅具有营养效果,而且还刺激存在于大肠的天然菌群中的健康促进微生物。

    Antiadhesive carbohydrates
    9.
    发明申请
    Antiadhesive carbohydrates 有权
    防粘碳水化合物

    公开(公告)号:US20070054877A1

    公开(公告)日:2007-03-08

    申请号:US11511500

    申请日:2006-08-29

    IPC分类号: A61K31/715

    摘要: Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C4 and C5 atom.

    摘要翻译: 提供了一种药物或饮食产品,其用于减少和/或阻断致病物质和生物体对真核细胞特别是哺乳动物细胞的粘附。 所述制剂包含至少一种在其一个端部具有糖醛酸单元的碳水化合物。 本发明的碳原子数为10〜100%的末端糖醛酸单元具有特别位于C 4〜C 5原子之间的双键。

    Antiadhesive carbohydrates
    10.
    发明申请
    Antiadhesive carbohydrates 失效
    防粘碳水化合物

    公开(公告)号:US20060105990A1

    公开(公告)日:2006-05-18

    申请号:US11313674

    申请日:2005-12-22

    IPC分类号: A61K31/715

    摘要: Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C4 and C5 atom.

    摘要翻译: 提供了一种药物或饮食产品,其用于减少和/或阻断致病物质和生物体对真核细胞特别是哺乳动物细胞的粘附。 所述制剂包含至少一种在其一个端部具有糖醛酸单元的碳水化合物。 本发明的碳原子数为10〜100%的末端糖醛酸单元具有特别位于C 4〜C 5原子之间的双键。